GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nova Leap Health Corp (TSXV:NLH) » Definitions » EV-to-EBIT

Nova Leap Health (TSXV:NLH) EV-to-EBIT : -15.48 (As of May. 12, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nova Leap Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nova Leap Health's Enterprise Value is C$24.69 Mil. Nova Leap Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$-1.60 Mil. Therefore, Nova Leap Health's EV-to-EBIT for today is -15.48.

The historical rank and industry rank for Nova Leap Health's EV-to-EBIT or its related term are showing as below:

TSXV:NLH' s EV-to-EBIT Range Over the Past 10 Years
Min: -161   Med: -10.58   Max: 115.49
Current: -15.48

During the past 7 years, the highest EV-to-EBIT of Nova Leap Health was 115.49. The lowest was -161.00. And the median was -10.58.

TSXV:NLH's EV-to-EBIT is ranked worse than
100% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.24 vs TSXV:NLH: -15.48

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Nova Leap Health's Enterprise Value for the quarter that ended in Sep. 2023 was C$16.48 Mil. Nova Leap Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$-1.60 Mil. Nova Leap Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -9.68%.


Nova Leap Health EV-to-EBIT Historical Data

The historical data trend for Nova Leap Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Leap Health EV-to-EBIT Chart

Nova Leap Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial -24.10 -49.63 72.81 14.70 -19.82

Nova Leap Health Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.06 -19.82 -19.89 -12.50 -10.33

Competitive Comparison of Nova Leap Health's EV-to-EBIT

For the Medical Care Facilities subindustry, Nova Leap Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Leap Health's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's EV-to-EBIT falls into.



Nova Leap Health EV-to-EBIT Calculation

Nova Leap Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=24.692/-1.595
=-15.48

Nova Leap Health's current Enterprise Value is C$24.69 Mil.
Nova Leap Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nova Leap Health  (TSXV:NLH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Nova Leap Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-1.595/16.4826275
=-9.68 %

Nova Leap Health's Enterprise Value for the quarter that ended in Sep. 2023 was C$16.48 Mil.
Nova Leap Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nova Leap Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Nova Leap Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Nova Leap Health (TSXV:NLH) Business Description

Traded in Other Exchanges
Address
7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of personal home care and support services. The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offering includes meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S operations. The company derives a majority of its revenue from the United States.
Executives
Christopher Donald Dobbin Director, Senior Officer

Nova Leap Health (TSXV:NLH) Headlines

No Headlines